PI
TEVA icon

PGGM Investments’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

PGGM Investments’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-610,249
Closed -$5.4M – 399
2023
Q1 		$5.4M Sell
610,249
-1,002,785
-62% -$9.92M 0.09% 194
2022
Q4 		$14.7M Hold
1,613,034
– – 0.26% 73
2022
Q3 		$13M Buy
+1,613,034
New +$14.3M 0.23% 88
2022
Q1 		$12.9M Hold
1,613,034
– – 0.06% 239
2021
Q4 		$12.9M Hold
1,613,034
– – 0.06% 239
2021
Q3 		$15.7M Hold
1,613,034
– – 0.08% 241
2021
Q2 		$16M Hold
1,613,034
– – 0.07% 236
2021
Q1 		$18.6M Hold
1,613,034
– – 0.08% 233
2020
Q4 		$15.6M Hold
1,613,034
– – 0.07% 238
2020
Q3 		$14.5M Hold
1,613,034
– – 0.08% 210
2020
Q2 		$19.9M Hold
1,613,034
– – 0.12% 184
2020
Q1 		$14.5M Hold
1,613,034
– – 0.1% 188
2019
Q4 		$15.8M Hold
1,613,034
– – 0.09% 192
2019
Q3 		$11.1M Hold
1,613,034
– – 0.05% 205
2019
Q2 		$14.9M Buy
1,613,034
+95,000
+6% +$1.15M 0.07% 194
2019
Q1 		$23.8M Buy
1,518,034
+610,000
+67% +$10.8M 0.12% 172
2018
Q4 		$14M Hold
908,034
– – 0.08% 204
2018
Q3 		$19.6M Hold
908,034
– – 0.1% 205
2018
Q2 		$22.1M Hold
908,034
– – 0.12% 195
2018
Q1 		$15.5M Hold
908,034
– – 0.09% 241
2017
Q4 		$17.2M Sell
908,034
-626,265
-41% -$9.42M 0.1% 235
2017
Q3 		$27M Buy
1,534,299
+6,202
+0.4% +$140K 0.13% 213
2017
Q2 		$50.8M Buy
1,528,097
+163,292
+12% +$5.05M 0.26% 97
2017
Q1 		$43.8M Sell
1,364,805
-36,479
-3% -$1.24M 0.23% 121
2016
Q4 		$50.8M Buy
1,401,284
+73,393
+6% +$2.93M 0.26% 98
2016
Q3 		$61.1M Sell
1,327,891
-17,037
-1% -$889K 0.31% 72
2016
Q2 		$67.6M Buy
1,344,928
+528,470
+65% +$28.1M 0.35% 66
2016
Q1 		$43.7M Buy
816,458
+173,514
+27% +$10.2M 0.23% 104
2015
Q4 		$42.2M Sell
642,944
-34,494
-5% -$2.13M 0.22% 107
2015
Q3 		$38.2M Buy
677,438
+28,582
+4% +$1.85M 0.21% 113
2015
Q2 		$38.3M Sell
648,856
-13,992
-2% -$863K 0.2% 120
2015
Q1 		$41.3M Sell
662,848
-63,237
-9% -$3.68M 0.2% 113
2014
Q4 		$41.8M Buy
726,085
+2,829
+0.4% +$158K 0.19% 121
2014
Q3 		$38.9M Buy
723,256
+53,515
+8% +$2.84M 0.18% 124
2014
Q2 		$35.1M Buy
669,741
+32,520
+5% +$1.66M 0.17% 132
2014
Q1 		$33.7M Buy
637,221
+22,057
+4% +$1.02M 0.18% 127
2013
Q4 		$24.7M Buy
615,164
+22,017
+4% +$867K 0.14% 187
2013
Q3 		$22.4M Sell
593,147
-350,834
-37% -$13.7M 0.13% 184
2013
Q2 		$37M Buy
+943,981
New +$36.8M 0.22% 145

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
IAM
Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

PGGM Investments's TEVA Position: Q2 2023 in Review

PGGM Investments sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q2 2023, closing a stake of 610,249 shares — an estimated $5.4M sold.

PGGM Investments first reported a position in TEVA in Q2 2013 and held it in 39 quarters. The position peaked at $67.6M in Q2 2016. 428 funds tracked by Wall St. Rank hold TEVA as of Q2 2023.

  • PGGM Investments reported no remaining Teva Pharmaceutical Industries Limited position as of Q2 2023 after selling out during the quarter.
  • PGGM Investments sold 610,249 Teva Pharmaceutical Industries Limited shares in Q2 2023, an estimated $5.4M.
  • PGGM Investments first reported a position in Teva Pharmaceutical Industries Limited in Q2 2013 and held it in 39 quarters.
  • PGGM Investments's Teva Pharmaceutical Industries Limited position peaked at $67.6M in Q2 2016.
  • 428 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q2 2023.

Based on PGGM Investments's 13F filing for Q2 2023, filed 7 Aug 2023.